BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 25279974)

  • 1. Role of SLCO1B1, ABCB1, and CHRNA1 gene polymorphisms on the efficacy of rocuronium in Chinese patients.
    Mei Y; Wang SY; Li Y; Yi SQ; Wang CY; Yang M; Duan KM
    J Clin Pharmacol; 2015 Mar; 55(3):261-8. PubMed ID: 25279974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of ABCB1 rs12720464 and rs1055302 polymorphisms in Chinese patients on the time course of action of rocuronium administered as a single dose.
    Qi TL; Zhou YH; Yuan JJ; Li ZS; Wang ZY; Chang YZ; Zhao EX; Cheng D; Hou JK; Tian Y; Chen GZ; Mao YY; Ren Y; Zhang LR; Kan QC; Zhang W
    Int J Clin Pharmacol Ther; 2016 Jun; 54(6):462-70. PubMed ID: 27087154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYP2C9*3(1075A > C), ABCB1 and SLCO1B1 genetic polymorphisms and gender are determinants of inter-subject variability in pitavastatin pharmacokinetics.
    Zhou Q; Chen QX; Ruan ZR; Yuan H; Xu HM; Zeng S
    Pharmazie; 2013 Mar; 68(3):187-94. PubMed ID: 23556337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of dyslipidemia and gene polymorphisms of ABCB1 and SLCO1B1 in Han, Uygur, Kazak, Hui, Tatar, Kirgiz, and Sibe populations with coronary heart disease in Xinjiang, China.
    Wang T; Sun L; Xu L; Zhao T; Feng J; Yu L; Wu J; Li H
    Lipids Health Dis; 2021 Sep; 20(1):116. PubMed ID: 34563206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variability in plasma rifampicin concentrations and role of
    Sileshi T; Makonnen E; Telele NF; Barclay V; Zumla A; Aklillu E
    Infect Dis (Lond); 2024 Apr; 56(4):308-319. PubMed ID: 38315168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simvastatin pharmacokinetics in healthy Chinese subjects and its relations with CYP2C9, CYP3A5, ABCB1, ABCG2 and SLCO1B1 polymorphisms.
    Zhou Q; Ruan ZR; Jiang B; Yuan H; Zeng S
    Pharmazie; 2013 Feb; 68(2):124-8. PubMed ID: 23469684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of SLCO1B1 and ABCB1 Genetic Variants with Atorvastatin-induced Myopathy in Patients with Acute Ischemic Stroke.
    Zhang L; Lv H; Zhang Q; Wang D; Kang X; Zhang G; Li X
    Curr Pharm Des; 2019; 25(14):1663-1670. PubMed ID: 31298164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The SLCO1A2 -189_-188InsA polymorphism reduces clearance of rocuronium in patients submitted to elective surgeries.
    Costa ACC; Coelho EB; Lanchote VL; Correia BV; Abumansur JT; Lauretti GR; de Moraes NV
    Eur J Clin Pharmacol; 2017 Aug; 73(8):957-963. PubMed ID: 28409297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influences of SLCO1B1 and ABCB1 genotypes on the pharmacokinetics of simvastatin, in relation to CYP3A4 inhibition.
    Jiang F; Choi JY; Lee JH; Ryu S; Park ZW; Lee JG; Na HS; Lee SY; Oh WY; Chung MW; Choi SE
    Pharmacogenomics; 2017 Apr; 18(5):459-469. PubMed ID: 28350522
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Srisuttayasathien M; Areepium N; Lertkhachonsuk R
    Per Med; 2021 Mar; 18(2):107-114. PubMed ID: 33565324
    [No Abstract]   [Full Text] [Related]  

  • 11. CYP3A5, ABCB1, and SLCO1B1 polymorphisms and pharmacokinetics and virologic outcome of lopinavir/ritonavir in HIV-infected children.
    Rakhmanina NY; Neely MN; Van Schaik RH; Gordish-Dressman HA; Williams KD; Soldin SJ; van den Anker JN
    Ther Drug Monit; 2011 Aug; 33(4):417-24. PubMed ID: 21743379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An integrated pharmacokinetic/pharmacogenomic analysis of ABCB1 and SLCO1B1 polymorphisms on edoxaban exposure.
    Vandell AG; Lee J; Shi M; Rubets I; Brown KS; Walker JR
    Pharmacogenomics J; 2018 Jan; 18(1):153-159. PubMed ID: 27897269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between statin-induced creatine kinase elevation and genetic polymorphisms in SLCO1B1, ABCB1 and ABCG2.
    Ferrari M; Guasti L; Maresca A; Mirabile M; Contini S; Grandi AM; Marino F; Cosentino M
    Eur J Clin Pharmacol; 2014 May; 70(5):539-47. PubMed ID: 24595600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repaglinide-irbesartan drug interaction: effects of SLCO1B1 polymorphism on repaglinide pharmacokinetics and pharmacodynamics in Chinese population.
    Pei Q; Liu JY; Yin JY; Yang GP; Liu SK; Zheng Y; Xie P; Guo CX; Luo M; Zhou HH; Li X; Liu ZQ
    Eur J Clin Pharmacol; 2018 Aug; 74(8):1021-1028. PubMed ID: 29748863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of association between SLCO1B1 polymorphism and the lipid-lowering effects of atorvastatin and simvastatin in Chinese individuals.
    Fu Q; Li YP; Gao Y; Yang SH; Lu PQ; Jia M; Zhang LR
    Eur J Clin Pharmacol; 2013 Jun; 69(6):1269-74. PubMed ID: 23263738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenetics of tamoxifen therapy in Asian populations: from genetic polymorphism to clinical outcomes.
    Wang T; Zhou Y; Cao G
    Eur J Clin Pharmacol; 2021 Aug; 77(8):1095-1111. PubMed ID: 33515076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between genetic polymorphisms of SLCO1B1 and susceptibility to methimazole-induced liver injury.
    Jin S; Li X; Fan Y; Fan X; Dai Y; Lin H; Cai W; Yang J; Xiang X
    Basic Clin Pharmacol Toxicol; 2019 Dec; 125(6):508-517. PubMed ID: 31240859
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Bharath G; Vishnuprabu DP; Preethi L; Nagappan AS; Dhianeshwaran Isravanya RT; Bhaskar LV; Swaminathan N; Munirajan AK
    Pharmacogenomics; 2022 Aug; 23(12):683-694. PubMed ID: 35968761
    [No Abstract]   [Full Text] [Related]  

  • 19. [Associations of SLCO1B1 polymorphisms with tacrolimus concentrations in Chinese renal transplant recipients].
    Liu S; Chen RX; Li J; Liu XM; Huang HB; Fu Q; Wang CX; Huang M; Li JL
    Yao Xue Xue Bao; 2016 Aug; 51(8):1240-4. PubMed ID: 29897725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SLCO1B1 rs4149056 genetic polymorphism predicting methotrexate toxicity in Chinese patients with non-Hodgkin lymphoma.
    Yang L; Wu H; Gelder TV; Matic M; Ruan JS; Han Y; Xie RX
    Pharmacogenomics; 2017 Nov; 18(17):1557-1562. PubMed ID: 29095107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.